Junji Saruwatari

15PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGlycoconjugatesPharmacogenomicsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 27, 2026
Risk Assessment of Neutropenia Based on Exposure Information Without Plasma Concentration Measurement in Pemetrexed-Platinum-Based Chemotherapy: A Modeling Approach Using Real-World Clinical Data.

|Jul 23, 2026
Sex-specific risk factors for genital infections associated with SGLT2 inhibitors in type 2 diabetes: a retrospective cohort study and disproportionality analysis using JADER.

|Jul 07, 2025
Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational Study.

Ayami Kajiwara-Morita, Kentaro Oniki, Akira Yoshida

|May 13, 2025
Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic-Pharmacodynamic and Machine Learning Analyses.

Keiichi Shigetome, Tomoko Egashira, Tetsu Tomita

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Dec 10, 2024
Drug-induced megacolon in schizophrenia: a pharmacovigilance study of antipsychotic medications from the Japanese Adverse Drug Event database: a disproportionality analysis.

Keita Tokumitsu, Norio Sugawara, Yuki Kondo

Pageof 3

Frequent Collaborators

7 joint publications

Kentaro Oniki

3 joint publications

Ayami Kajiwara-Morita

3 joint publications

Norio Yasui-Furukori

2 joint publications

Hiroshi Watanabe